Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

https://websitem.gazi.edu.tr/site/yilmazduyguusta/academic

Other IDs

ResearcherID: A-5496-2018
Scopus Author ID: 57193733907

Keywords

Pharmacy, Pharmaceutical Technology, Biopharmaceutics & Pharmacokinetics

Countries

Türkiye

Activities

Collapse all

Employment (1)

Gazi University: Ankara, Ankara, TR

2024-01-23 to present | Assistant Professor (Division of Biopharmaceutics & Pharmacokinetics, Department of Pharmaceutical Technology)
Employment
Source: Self-asserted source
DUYGU YILMAZ USTA

Education and qualifications (2)

Gazi University: Ankara, Ankara, TR

2014-09-01 to 2022-02-17 | PhD (Division of Biopharmaceutics & Pharmacokinetics, Department of Pharmaceutical Technology)
Education
Source: Self-asserted source
DUYGU YILMAZ USTA

Gazi University: Ankara, Ankara, TR

2009-09-01 to 2014-01-21 | Bachelor (Faculty of Pharmacy)
Education
Source: Self-asserted source
DUYGU YILMAZ USTA

Funding (1)

Development of Solid Self Emulsifying Drug Delivery Systems and In Vitro - In Vivo Evaluations

Grant
Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (ANKARA, TR)
GRANT_NUMBER:

217S602
Source: Self-asserted source
DUYGU YILMAZ USTA

Works (16)

Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye

Dissolution Technologies
2024 | Journal article
DOI: 10.14227/DT310124P40
WOSUID: WOS:001179723200008
Contributors: Coban, Ozlem; Usta, Duygu Yilmaz; Pinar, Sila Gulbag
Source: check_circle
Web of Science Researcher Profile Sync

Optimization and validation of HPLC methods for<i> in</i><i> vitro</i> and<i> ex</i><i> vivo</i> analyses of bosentan monohydrate in FDA-recommended and biorelevant media

Istanbul Journal of Pharmacy
2024 | Journal article
DOI: 10.26650/ISTANBULJPHARM.2024.1419998
WOSUID: WOS:001406485200021
Contributors: Usta, Duygu Yilmaz; Olgac, Seval; Teksin, Zeynep Safak
Source: check_circle
Web of Science Researcher Profile Sync

Lipid Based Delivery Systems-I: Overview of Self-Emulsifying Drug Delivery System Formulations: Traditional Review

Journal of Literature Pharmacy Sciences
2024-11-29 | Journal article
DOI: 10.5336/pharmsci.2024-104970
Part of ISSN: 2630-5569
Contributors: Duygu YILMAZ USTA; Zeynep Şafak TEKSİN
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 2)‎

Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation

AAPS PharmSciTech
2024-05-31 | Journal article
DOI: 10.1208/s12249-024-02831-9
Contributors: Duygu Yılmaz Usta; Zeynep Safak Teksin; Fatmanur Tugcu-Demiroz
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Development and pharmacokinetic evaluation of Neusilin (R) US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS (R) real-time biodistribution, and ex-vivo imaging

International Journal of Pharmaceutics
2023 | Journal article
DOI: 10.1016/J.IJPHARM.2023.123219
WOSUID: WOS:001052117400001
Contributors: Yilmaz Usta, Duygu; Olgac, Seval; Timur, Burcu; Teksin, Zeynep Safak
Source: check_circle
Web of Science Researcher Profile Sync

Uzun Zincirli Mono ve Digliserit Karişimlari ile Hazırlanan Bosentan Monohidrat Yüklü Kendiliğinden Nanoemülsifiye İlaç Taşiyici Sistemlerin (SNEDDS) Formülasyonu

2022 | Patent
Contributors: DUYGU YILMAZ USTA; Zeynep Şafak TEKSİN
Source: Self-asserted source
DUYGU YILMAZ USTA

Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model

Journal of Drug Delivery Science and Technology
2022-11 | Journal article
DOI: 10.1016/j.jddst.2022.103797
Part of ISSN: 1773-2247
Contributors: DUYGU YILMAZ USTA
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 2)‎

Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media.

AAPS PharmSciTech
2022-07-26 | Journal article
DOI: https://doi.org/10.1208/s12249-022-02355-0
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 2)‎

Formulation development, optimization by Box- Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment

European Journal of Pharmaceutical Sciences
2022-03-06 | Journal article
DOI: 10.1016/j.ejps.2022.106159
Part of ISSN: 0928-0987
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 3)‎

Role of Surfactants on Dissolution Behavior of Tamoxifen

Dissolution Technologies
2021 | Journal article
DOI: 10.14227/DT280221P6
WOSUID: WOS:000658410800003
Contributors: Incecayir, Tuba; Olgac, Seval; Usta, Duygu Yilmaz; Teksin, Zeynep Safak
Source: check_circle
Web of Science Researcher Profile Sync

Comparison of Tablet Splitting Techniques for Dosing Accuracy of Nebivolol Tablets: Hand Splitting versus Tablet Cutter and Knife

Saudi Pharmaceutical Journal
2021-11 | Journal article
DOI: 10.1016/j.jsps.2021.11.005
Part of ISSN: 1319-0164
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 2)‎

Role of Surfactants on Dissolution Behavior of Tamoxifen

Dissolution Technologies
2021-06-01 | Journal article
Part of DOI: 10.14227/DT280221P6
Part of ISSN: 1521-298X
Source: Self-asserted source
DUYGU YILMAZ USTA

Biopharmaceutics, Pharmacokinetics and Patent Evaluations of Drugs Used in the Treatment of COVID-19: Current Status in the Development of Generic Drugs in Turkey

Gazi Medical Journal
2020-09-01 | Journal article
DOI: 10.12996/gmj.2020.119
Part of ISSN: 2147-2092
Source: Self-asserted source
DUYGU YILMAZ USTA
grade
Preferred source (of 3)‎

Evaluation of in vitro dissolution characteristics of flurbiprofen, a BCS class IIa drug

Fabad Journal of Pharmaceutical Sciences
2018 | Journal article
EID:

2-s2.0-85047804381

Part of ISBN:

13004182
Contributors: Yilmaz Usta, D.; Demi Rtas, Ö.; ÖkÇelik, C.; Uslu, A.; Teksi̇n, Z.Ş.
Source: Self-asserted source
DUYGU YILMAZ USTA via Scopus - Elsevier

New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system

Pharmaceutical Development and Technology
2018 | Journal article
DOI: 10.1080/10837450.2017.1345941
EID:

2-s2.0-85024488279

Part of ISBN:

10979867 10837450
Contributors: Gülbağ, S.; Yılmaz Usta, D.; Gültekin, H.E.; Oktay, A.N.; Demirtaş, Ö.; Karaküçük, A.; Çelebi, N.
Source: Self-asserted source
DUYGU YILMAZ USTA via Scopus - Elsevier
grade
Preferred source (of 2)‎

New approaches to in vitro dissolution rate studies,İn Vitro Çözünme Hizi Çalişmalarinda Yeni Yaklaşimlar

Fabad Journal of Pharmaceutical Sciences
2015 | Journal article
EID:

2-s2.0-85016174405

Part of ISBN:

13004182
Contributors: Yilmaz Usta, D.; Teksin, Z.Ş.
Source: Self-asserted source
DUYGU YILMAZ USTA via Scopus - Elsevier
How many people are using ORCID?